CCWP
BSX icon

Cedar Cove Wealth Partners’s Boston Scientific BSX Stock Holding History

Cedar Cove Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,828
Closed -$303K – 96
2026
Q1 		$303K Sell
4,828
-202
-4% -$16.2K 0.16% 77
2025
Q4 		$480K Buy
+5,030
New +$493K 0.25% 54

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Cedar Cove Wealth Partners's BSX Position: Q2 2026 in Review

Cedar Cove Wealth Partners sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,828 shares — an estimated $303K sold.

Cedar Cove Wealth Partners first reported a position in BSX in Q4 2025 and held it in 2 quarters. The position peaked at $480K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Cedar Cove Wealth Partners reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Cedar Cove Wealth Partners sold 4,828 Boston Scientific shares in Q2 2026, an estimated $303K.
  • Cedar Cove Wealth Partners first reported a position in Boston Scientific in Q4 2025 and held it in 2 quarters.
  • Cedar Cove Wealth Partners's Boston Scientific position peaked at $480K in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cedar Cove Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.